N/A N=10 Treatment

Treating Non-epileptic Seizures Using Magnetic Brain Stimulation

Nonepileptic Seizures

Bottom Line

View on ClinicalTrials.gov: NCT02796924 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2020

Primary outcome: Primary: Number of Weekly Psychogenic Non-epileptic Seizure-events — 6.9; 5.3 events

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: MagStim Rapid2 Transcranial Magnetic Simulation (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Manitoba
Primary completion: Apr 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Weekly Psychogenic Non-epileptic Seizure-events	6.9; 5.3	—

Summary

The purpose of this study is to investigate the feasibility of using repetitive transcranial magnetic stimulation (rTMS) - a form of non-invasive brain stimulation - to decrease the frequency of psychogenic non-epileptic seizure (PNES) episodes in patients with PNES.

Eligibility Criteria

Inclusion Criteria

Confirmed Psychogenic Non-Epileptic Seizures

Exclusion Criteria

Evidence of previous or comorbid epileptic seizures
Major comorbid neurological diseases
Currently taking medications that are known to reduce seizure-threshold
Currently pregnant

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02796924). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.